SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 238 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,085 | -99.9% | 8,370 | -31.6% | 0.11% | -4.4% |
| Q1 2022 | $956,000 | +231.9% | 12,240 | +229.9% | 0.11% | +289.7% |
| Q2 2021 | $288,000 | -67.7% | 3,710 | -50.4% | 0.03% | -80.1% |
| Q1 2019 | $891,000 | +217.1% | 7,478 | +97.2% | 0.15% | +247.6% |
| Q1 2018 | $281,000 | +28.9% | 3,792 | -41.3% | 0.04% | +2.4% |
| Q2 2017 | $218,000 | +4.3% | 6,462 | -8.2% | 0.04% | -16.3% |
| Q1 2017 | $209,000 | – | 7,038 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |